Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cancidas for Antifungal Prophylaxis in High-Risk Liver Transplant Patients
NCT01260974Phase 2Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- May 2009
- Primary completion
- Nov 2012
- Countries
- 1
01
Overview
A Phase 2 trial of caspofungin in fungemia, mycosis, sponsored by Azienda Ospedaliero-Universitaria di Padova. Status: unknown.
02
Drugs
caspofungin
03
Conditions
fungemiamycosis
Beyond the preview
Go deeper on NCT01260974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01260974.